Gupta Amit reported option exercise involving 18,750 derivative units of Cardlytics, Inc. at $0.00 for $0 on Oct 1, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Chief Executive Officer
Chief Executive Officer
Filed Oct 2, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
18,750Restricted Stock Units
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
112,500Direct
Trade date
Oct 1, 2026Option exercise
Filed
Oct 2, 2026, 5:30 PM ET1-day reporting delay
Accession
0001628280-26-064668Code M · Transaction 235505
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Oct 1, 2026Option exercise12,500$0.00$0Trade 235506
Oct 1, 2026Sell10,351$2.71−$28,051.21Trade 235503
Oct 2, 2026Sell7,382$2.53−$18,698.61Trade 235504
Oct 1, 2026Option exercise18,750——Trade 235501
Oct 1, 2026Option exercise12,500——Trade 235502
6 transaction rows in this filing. Joint filers share the same rows.

CDLX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CDLX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +47%1w ago +36%1d ago +16%
Returns since7d −19%30d −30%90d180d1y

Footnotes in full

F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $2.62 to $2.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2). F3: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $2.48 to $2.635, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3). F4: The RSUs vest in equal amounts quarterly over a two-year period through April 1, 2028, provided that the Reporting Person remains employed by the Issuer on such vesting dates. F5: 50% of the shares underlying the RSU award vested on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates.